Epstein-Barr Virus-Associated Smooth Muscle Tumor After Kidney Transplantation: A French Multicenter Retrospective Study.

Laurène TardieuDany AnglicheauRebecca Sberro-SoussanMathilde LemoineLéonard GolbinOphélie FourdinierJulie BruneauMarina CharbitTchao MeatchiJean-Emmanuel SerreMoglie Le QuintrecAlexandre KarrasEric ThervetHélène Lazareth

Published in: Clinical transplantation (2024)

PT-SMT is a subacute and progressive disease during kidney transplantation. Even if the risk of developing PT-SMT is low in kidney transplant recipients (0.07% in our cohort), PT-SMT is associated with significant graft loss, possibly due to reduced immunosuppression. Developing guidelines could help transplantation teams better manage these patients.

Keyphrases

epstein barr virus
smooth muscle
kidney transplantation
end stage renal disease
ejection fraction
diffuse large b cell lymphoma
newly diagnosed
multiple sclerosis
prognostic factors
stem cells
patient reported outcomes
cell therapy
mesenchymal stem cells
double blind